ATE329583T1 - Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib - Google Patents

Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib

Info

Publication number
ATE329583T1
ATE329583T1 AT01964122T AT01964122T ATE329583T1 AT E329583 T1 ATE329583 T1 AT E329583T1 AT 01964122 T AT01964122 T AT 01964122T AT 01964122 T AT01964122 T AT 01964122T AT E329583 T1 ATE329583 T1 AT E329583T1
Authority
AT
Austria
Prior art keywords
molded article
preparation containing
medicinal preparation
rapidly dissolving
oral medicinal
Prior art date
Application number
AT01964122T
Other languages
English (en)
Inventor
Tugrul T Kararli
Mark J Kontny
Trang T Le
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Application granted granted Critical
Publication of ATE329583T1 publication Critical patent/ATE329583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
AT01964122T 2000-08-18 2001-08-17 Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib ATE329583T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22648700P 2000-08-18 2000-08-18

Publications (1)

Publication Number Publication Date
ATE329583T1 true ATE329583T1 (de) 2006-07-15

Family

ID=22849097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964122T ATE329583T1 (de) 2000-08-18 2001-08-17 Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib

Country Status (14)

Country Link
US (1) US20020071857A1 (de)
EP (1) EP1309315B1 (de)
JP (1) JP2004506680A (de)
AT (1) ATE329583T1 (de)
AU (1) AU2001285011A1 (de)
CA (1) CA2419592A1 (de)
CY (1) CY1105319T1 (de)
DE (1) DE60120710T2 (de)
DK (1) DK1309315T3 (de)
ES (1) ES2265439T3 (de)
MX (1) MXPA03001407A (de)
NZ (1) NZ524124A (de)
PT (1) PT1309315E (de)
WO (1) WO2002015884A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026623A1 (en) * 2001-09-26 2003-04-03 Pharmacia Corporation Intraorally disintegrating valdecoxib compositions
AP2004003022A0 (en) * 2001-10-10 2004-06-30 Pharmacia Corp Intraorally disintergrating valdecoxib compositions prepared by spray drying process
AU2002357046A1 (en) * 2001-12-07 2003-06-23 Merck And Co., Inc. Combination therapy comprising a cyclooygenase-2 inhibitor
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
WO2004000284A1 (en) * 2002-06-21 2003-12-31 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20060052432A1 (en) * 2002-09-20 2006-03-09 Julius Remenar Pharmaceutical compositions with improved dissolution
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
CA2524806C (en) * 2003-05-07 2011-07-12 Akina, Inc. Highly plastic granules for making fast melting tablets
BRPI0302736B8 (pt) * 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
AU2005320672B2 (en) * 2004-12-27 2011-01-06 Astellas Pharma Inc. Stable particulate pharmaceutical composition of solifenacin or salt thereof
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CN104688697A (zh) * 2005-03-07 2015-06-10 拜尔健康护理有限责任公司 用于治疗癌症的包含ω-羧芳基取代的二苯基脲的药物组合物
CN101222911A (zh) * 2005-07-15 2008-07-16 特瓦制药工业有限公司 新的制粒方法及由此制备的颗粒
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US20090048237A1 (en) * 2007-08-07 2009-02-19 Acelrx Pharmaceuticals, Inc. Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
WO2009063367A1 (en) * 2007-11-15 2009-05-22 Pfizer Products Inc. Dosage forms comprising celecoxib providing both rapid and sustained pain relief
KR101306537B1 (ko) 2008-06-04 2013-09-09 콜게이트-파아므올리브캄파니 캐비테이션 시스템을 가진 구강 관리기구
US20100075930A1 (en) * 2008-09-03 2010-03-25 Yoel Ovil Salicylic salt compositions and related method of treatment of cardiac conditions
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US9259420B2 (en) * 2012-09-13 2016-02-16 Cba Pharma, Inc. Tetrandrine pharmaceutical formulations
SG11201704797TA (en) 2014-12-23 2017-07-28 Acelrx Pharmaceuticals Inc Systems, devices and methods for dispensing oral transmucosal dosage forms
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
EP3740284A4 (de) * 2018-01-21 2021-10-13 Kastner, Bernie D. Präparat und verfahren zur behandlung von migräne

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
KR100256147B1 (ko) * 1991-12-24 2000-08-01 오노다 마사요시 구강내 붕해성 제제 및 이의 제조방법
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
PE10898A1 (es) * 1995-06-13 1998-03-20 American Home Prod Formulaciones orales de etodolac s (+)-
BR9709097A (pt) * 1996-05-17 1999-08-03 Merck & Co Inc Composição farmacêutica para o tratamento de doenças mediadas por ciclooxigenase processo para tratar uma doença inflamatória suscetível de tratamento com um agente antinflamatório n o esteróide uso e forma oral de dose unitária
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
JP2002529406A (ja) * 1998-11-12 2002-09-10 メルク エンド カムパニー インコーポレーテッド ＧＡＢＡＡα５逆活性薬と、ＣＯＸ−２阻害剤、ＮＳＡＩＤ、エストロゲン、又はビタミンＥとの組合わせ
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
AU3221401A (en) * 1999-11-30 2001-06-12 Rajesh Jain Fast dissolving composition with prolonged sweet taste

Also Published As

Publication number Publication date
AU2001285011A1 (en) 2002-03-04
WO2002015884A3 (en) 2002-07-25
DK1309315T3 (da) 2006-10-09
DE60120710D1 (de) 2006-07-27
JP2004506680A (ja) 2004-03-04
NZ524124A (en) 2004-09-24
CA2419592A1 (en) 2002-02-28
EP1309315B1 (de) 2006-06-14
DE60120710T2 (de) 2007-06-14
CY1105319T1 (el) 2010-03-03
EP1309315A2 (de) 2003-05-14
MXPA03001407A (es) 2003-06-06
ES2265439T3 (es) 2007-02-16
WO2002015884A2 (en) 2002-02-28
PT1309315E (pt) 2006-09-29
US20020071857A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
ATE329583T1 (de) Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
EP1120109A3 (de) Feste schnell zerfallende und sich auflösende Dosierungsformen
AU1227899A (en) Osmotic medicament releasing system
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
CN101371845B (zh) 一种用于治疗口腔溃疡药物组合物
RS52374B (en) FORMS OF MEDICINES WITH IMPROVED PHARMACOKINETIC CHARACTERISTICS
NO20070887L (no) Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
EA200001201A2 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2012173581A4 (en) Thiocolchicoside, etodolac and famotidine combinations
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
SE8901003D0 (sv) Snabbloesliga preparat
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
NO20034417D0 (no) Engangs vaginalkanyle for samtidig administrasjon av medikamenter i ulike former
Kapse et al. Co-processed superdisintegrants: Novel technique for design orodispersible tablets
ATE266404T1 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
TW201717916A (zh) 超高速崩解錠劑及其製造方法
ES2122630T3 (es) Forma medicamentosa de carbamazepina con liberacion retardada del principio activo.
Pandey et al. Orodispersible tablets-a review
WO2010019279A8 (en) Pharmaceutical compositions configured to deter dosage form splitting
AR020998A1 (es) Formulaciones de liberacion controlada de metamizol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1309315

Country of ref document: EP

REN Ceased due to non-payment of the annual fee